Table 1.
The correlation between DLGAP1-AS2 expression and the clinicopathological characteristics of GC.
| Features | High expression (n = 42) | Low expression (n = 43) | P |
|---|---|---|---|
| Gender | |||
| Male | 33 | 31 | 0.489 |
| Female | 9 | 12 | |
| Age | |||
| <60 | 9 | 8 | 0.745 |
| ≥60 | 33 | 35 | |
| Drink | |||
| NO | 35 | 34 | 0.615 |
| YES | 7 | 9 | |
| Smoke | |||
| NO | 33 | 31 | 0.489 |
| YES | 9 | 12 | |
| Tumor size | |||
| < 5 cm | 22 | 28 | 0.233 |
| ≥5 cm | 20 | 15 | |
| Differentiation | |||
| Moderate | 13 | 19 | 0.208 |
| Poor | 29 | 24 | |
| Lymphatic metastasis | |||
| Negative | 14 | 24 | 0.037 |
| Positive | 28 | 19 | |
| Venous invasion | |||
| Negative | 33 | 38 | 0.223 |
| Positive | 9 | 5 | |
| TNM stages | |||
| I/II | 14 | 24 | 0.037 |
| III/IV | 28 | 19 | |